Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boos

Showing results (41-50 of 257) with videos related to

Pageof 26
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2005
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and strokeGregory Y H Lip, Christopher J Boos
Journal of Clinical Hypertension (Greenwich, Conn.)|January 18, 2024
Ambulatory arterial stiffness index, mortality, and adverse cardiovascular outcomes; Systematic review and meta-analysisChristopher J Boos, Aung Hein, Ahmed Khattab
Journal of Human Hypertension|August 12, 2005
Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trialsC J Boos, G Y H Lip
Thrombosis Research|April 22, 2006
Ximelagatran: an eulogyChristopher J Boos, Gregory Y H Lip
Journal of Thrombosis and Thrombolysis|November 2, 2005
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effectChristopher J Boos, Gregory Y H Lip
Postgraduate Medical Journal|May 30, 2008
Antithrombotic treatment in atrial fibrillationG Y H Lip, C J Boos
Thrombosis Research|October 19, 2006
Assessment of mean platelet volume in coronary artery disease - what does it mean?Christopher J Boos, Gregory Y H Lip
Current Pharmaceutical Design|May 30, 2006
Is hypertension an inflammatory process?Christopher J Boos, Gregory Y H Lip
Journal of Thrombosis and Haemostasis : JTH|October 10, 2006
Platelet activation and cardiovascular outcomes in acute coronary syndromesC J Boos, G Y H Lip
International Journal of Cardiology|December 29, 2016
Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulantLouise A E Brown, Christopher J Boos
Pageof 26

Showing results (41-50 of 257) with videos related to

Sort By:
Pageof 26
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2005
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and strokeGregory Y H Lip, Christopher J Boos
Journal of Clinical Hypertension (Greenwich, Conn.)|January 18, 2024
Ambulatory arterial stiffness index, mortality, and adverse cardiovascular outcomes; Systematic review and meta-analysisChristopher J Boos, Aung Hein, Ahmed Khattab
Journal of Human Hypertension|August 12, 2005
Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trialsC J Boos, G Y H Lip
Thrombosis Research|April 22, 2006
Ximelagatran: an eulogyChristopher J Boos, Gregory Y H Lip
Journal of Thrombosis and Thrombolysis|November 2, 2005
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effectChristopher J Boos, Gregory Y H Lip
Postgraduate Medical Journal|May 30, 2008
Antithrombotic treatment in atrial fibrillationG Y H Lip, C J Boos
Thrombosis Research|October 19, 2006
Assessment of mean platelet volume in coronary artery disease - what does it mean?Christopher J Boos, Gregory Y H Lip
Current Pharmaceutical Design|May 30, 2006
Is hypertension an inflammatory process?Christopher J Boos, Gregory Y H Lip
Journal of Thrombosis and Haemostasis : JTH|October 10, 2006
Platelet activation and cardiovascular outcomes in acute coronary syndromesC J Boos, G Y H Lip
International Journal of Cardiology|December 29, 2016
Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulantLouise A E Brown, Christopher J Boos
Pageof 26